SANGUEDOLCE, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 1.964
EU - Europa 1.248
AS - Asia 270
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.492
Nazione #
US - Stati Uniti d'America 1.964
IT - Italia 285
UA - Ucraina 268
FI - Finlandia 259
CN - Cina 226
IE - Irlanda 97
DE - Germania 77
SE - Svezia 65
GB - Regno Unito 58
BE - Belgio 36
RO - Romania 33
RU - Federazione Russa 33
KR - Corea 19
FR - Francia 15
IN - India 13
EU - Europa 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IR - Iran 4
NL - Olanda 4
TN - Tunisia 4
AT - Austria 3
LB - Libano 3
TR - Turchia 3
ES - Italia 2
GR - Grecia 2
PL - Polonia 2
BY - Bielorussia 1
HK - Hong Kong 1
JP - Giappone 1
MA - Marocco 1
Totale 3.492
Città #
Ann Arbor 243
Chandler 241
Fairfield 157
Jacksonville 147
Woodbridge 140
Wilmington 121
Des Moines 117
Dublin 88
Houston 79
Ashburn 76
Medford 68
Seattle 58
Nanjing 54
Cambridge 50
Palermo 47
Princeton 43
Brussels 36
Tulsa 35
Altamura 30
Boardman 30
Dearborn 30
Lawrence 21
Beijing 20
Seongnam 19
Nanchang 18
Hebei 17
Shenyang 17
Auburn Hills 16
Jinan 16
San Diego 15
Changsha 12
Milan 12
Helsinki 10
Jiaxing 10
Tianjin 10
Saint Petersburg 9
Venice 9
Kumar 8
Ningbo 8
Partinico 8
Falls Church 7
San Mateo 7
Verona 7
Zhengzhou 7
Hefei 5
Kunming 5
Lanzhou 5
Los Angeles 5
Bremen 4
Hangzhou 4
Menlo Park 4
San Paolo di Civitate 4
Taizhou 4
Tehran 4
Düsseldorf 3
Hanover 3
Henderson 3
Izmir 3
London 3
Prague 3
Seelze 3
Taiyuan 3
Terrasini 3
Andover 2
Cattolica 2
Fuzhou 2
Guangzhou 2
Indiana 2
Kiev 2
Lentini 2
Partanna 2
Regensburg 2
Aarau 1
Alcamo 1
Amsterdam 1
Baotou 1
Barcelona 1
Buffalo 1
Catania 1
Cedar Knolls 1
Central District 1
Como 1
Den Haag 1
Favara 1
Francofonte 1
Frankfurt Am Main 1
Fremont 1
Groningen 1
Haikou 1
Kagoshima 1
Leawood 1
Ludwigshafen 1
Mainz 1
Messina 1
Montaione 1
Montalto Dora 1
Morgantown 1
Moscow 1
Mumbai 1
Napoli 1
Totale 2.290
Nome #
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 188
Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients. 167
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma 143
Clinical relevance of thymidylate syntetase expression in the signet ring cell histotype component of colorectal carcinoma 136
Thymidylate Synthase polymorphism and microsatellite instability: association in colorectal cancer 121
Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer 117
Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients. 110
Analysis of the thymidylate syntethase gene structure in colorectal cancer patients, and its possible relation with the 5-fluoruracil drug response 109
Difference in Ki67 and Thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients 104
Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and lts Possible Relation with the S-Fluorouracil Drug Response 103
Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma. 102
La Real Casa dei Matti di Palermo: storia di un'innovazione terapeutica tra architettura e letteratura 102
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 99
Low cell proliferation marker and low thymidylate synthase levels in the highly aggressive signet ring cell variant histotype of colorectal carcinoma 95
LOW CELL PROLIFERATION AND LOW THYMIDYLATE SYNTHASE LEVELS IN THE HIGHLY AGGRESSIVE SIGNET RING CELL VARIANT HISTOTYPE OF COLORECTAL CARCINOMA 94
Analysis of coding and non-coding regions of thymidylate syntetase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response 91
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients. european society for the study of purine and pyrimidine metabolism in man 87
Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer 87
Relationship between Thymidylate synthase and p53 and response versus taxane adjuvant chemotherapy for breast carcinoma 85
DIFFERENT EXPRESSION OF E-CADHERINE, BETA-CATENIN, AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL COLORECTAL CARCINOMA. 83
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 82
The significance of the Thymidylate Synthase expression in the Signet Ring Cell component of colorectal carcinoma 80
Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer 77
Myeloid zinc finger 1 regulates thymidylate synthase expression in patients with metastatic colorectal cancer showing the same promoter gene polymorphism 75
Could a variant structural form of thymidylate synthase gene of metastatic colorectal cancer patients be related with the poor response to 5 Fu treatment? 72
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophosphamide, methotrexate, 5-fluorouracil chemotherapy(CMF) versus docetaxel (TXT) in locally advanced carcinoma of the breast. 64
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients 63
Different expression of e-cadherin, beta-catenin and fibronectin in signet ring cell, and intestinal colorectal carcinoma 62
Relationdhip between the thymidylate synthase, P53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of breast 61
Relationship between the thymidiylate synthase, P53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of the breast 61
Possible role of differential metalloproteinase 1 expression in signet ring cell and intestinal colorectal carcinoma histotypes 60
Difference in ki67 and Thimidylate Synthase expressin in primary tumour compared with metastatic nodes in breast cancer patients 58
DIFFERENT EXPRESSION OF E-CADERINE, BETA CATENIN AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL CARCINOMA. 58
Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder? 55
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 52
RELATIONSHIP BETWEEN THE THYMIDYLATE SYNTHASE, p53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINAMO OF THE BREAST 52
DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST 50
Decreased expression of thymidylate synthase and low proliferation index assessed by ki67 in " signet ring cell component" of colorectal carcinomas 48
Decreased expression of thymidylate synthase and low proliferation index by Ki67 in "signet ring cell component of colorectal carcinoma" 48
Relationship between the thymidylate synthase, p53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of breast. 47
RELATIONSHIP BETWEEN THYMIDYLATE SYNTHASE EXPRESSION AND p53 LEVELS WITH THE TREATMENT BY CYCLOPHOSPHAMIDE, 5-FLUOROURACIL CHEMOTHERAPY (CMF) VERSUS DOCETAXEL IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST. 43
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophsphamide, methotrexate, 5-fluorouracil chemotherapy ( CMF)versus docetaxel ( TXT) in locally advanced carcinoma of the breast 41
Expression of a specific Thymidylate synthase polimorfic allele in metastatic colorectal patients is regulated by Myeloid Zinc Finger 1. 39
Low cell proliferation marker and low thymidylate synthase levels in the highly aggressive signet ring cell variant histotype of colorectal carcinoma 18
null 8
Totale 3.597
Categoria #
all - tutte 8.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019229 0 0 5 5 4 45 49 9 18 14 37 43
2019/2020732 110 26 47 23 68 87 82 24 71 94 59 41
2020/2021553 12 43 9 144 72 10 41 22 67 26 52 55
2021/2022450 17 105 4 15 22 16 15 20 71 44 28 93
2022/2023709 90 103 10 76 74 115 99 39 68 3 23 9
2023/202483 11 56 16 0 0 0 0 0 0 0 0 0
Totale 3.597